Honokiol antagonizes doxorubicin resistance in human breast cancer via miR-188-5p/FBXW7/c-Myc pathway
出版年份 2021 全文链接
标题
Honokiol antagonizes doxorubicin resistance in human breast cancer via miR-188-5p/FBXW7/c-Myc pathway
作者
关键词
-
出版物
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-02-05
DOI
10.1007/s00280-021-04238-w
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Overcoming acquired resistance of EGFR‐mutant NSCLC cells to the third generation EGFR inhibitor, osimertinib, with the natural product honokiol
- (2020) Hongjing Zang et al. Molecular Oncology
- FBXW7 in Cancer: What Has Been Unraveled Thus Far?
- (2019) Bethsebie Lalduhsaki Sailo et al. Cancers
- Honokiol alleviates sepsis-induced acute kidney injury in mice by targeting the miR-218-5p/heme oxygenase-1 signaling pathway
- (2019) Tao Zhang et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- Aberrantly expressed miR-188-5p promotes gastric cancer metastasis by activating Wnt/β-catenin signaling
- (2019) Yun Li et al. BMC CANCER
- miR‐188‐5p emerges as an oncomiRNA to promote gastric cancer cell proliferation and migration via upregulation of SALL4
- (2019) Mei Wang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Systems biology-based investigation of cooperating microRNAs as monotherapy or adjuvant therapy in cancer
- (2019) Xin Lai et al. NUCLEIC ACIDS RESEARCH
- LINC00668 promotes tumorigenesis and progression through sponging miR-188–5p and regulating USP47 in colorectal cancer
- (2019) Shuai Yan et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- MicroRNA‐188‐5p promotes apoptosis and inhibits cell proliferation of breast cancer cells via the MAPK signaling pathway by targeting Rap2c
- (2019) Xinying Zhu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Morin inhibits proliferation and induces apoptosis by modulating miR-188-5p/PTEN/AKT regulatory pathway in CML cells
- (2019) Ziyuan Nie et al. MOLECULAR CANCER THERAPEUTICS
- miR‐188‐5p suppresses cellular proliferation and migration via IL6ST: A potential noninvasive diagnostic biomarker for breast cancer
- (2019) Mei Wang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- MicroRNAs Involved in Carcinogenesis, Prognosis, Therapeutic Resistance, and Applications in Human Triple-Negative Breast Cancer
- (2019) Lei Ding et al. Cells
- Honokiol: A Review of Its Anticancer Potential and Mechanisms
- (2019) Chon Phin Ong et al. Cancers
- MiR-188-5p suppresses gastric cancer cell proliferation and invasion via targeting ZFP91
- (2018) Yuping Peng et al. ONCOLOGY RESEARCH
- Safety and Toxicology of Magnolol and Honokiol
- (2018) Andrea Sarrica et al. PLANTA MEDICA
- Chemotherapy induces enrichment of CD47+/CD73+/PDL1+immune evasive triple-negative breast cancer cells
- (2018) Debangshu Samanta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Chemosensitizing effect of honokiol in oral carcinoma stem cells via regulation of IL-6/Stat3 signaling
- (2018) Min-Te Chang et al. ENVIRONMENTAL TOXICOLOGY
- Triptolide Attenuates Renal Tubular Epithelial-mesenchymal Transition Via the MiR-188-5p-mediated PI3K/AKT Pathway in Diabetic Kidney Disease
- (2018) Mei Xue et al. International Journal of Biological Sciences
- MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
- (2017) Rajesha Rupaimoole et al. NATURE REVIEWS DRUG DISCOVERY
- Activation of tumor suppressor LKB1 by honokiol abrogates cancer stem-like phenotype in breast cancer via inhibition of oncogenic Stat3
- (2017) S Sengupta et al. ONCOGENE
- 27-Hydroxycholesterol increases Myc protein stability via suppressing PP2A, SCP1 and FBW7 transcription in MCF-7 breast cancer cells
- (2016) Li-Ming Ma et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Regulation of Mucin 1 and multidrug resistance protein 1 by honokiol enhances the efficacy of doxorubicin-mediated growth suppression in mammary carcinoma cells
- (2016) Padmamalini Thulasiraman et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
- (2016) Giampaolo Bianchini et al. Nature Reviews Clinical Oncology
- Loss of FBXW7 and accumulation of MCL1 and PLK1 promote paclitaxel resistance in breast cancer
- (2016) Jessica Gasca et al. Oncotarget
- microRNA expression profiling on individual breast cancer patients identifies novel panel of circulating microRNA for early detection
- (2016) Rimi Hamam et al. Scientific Reports
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- MYC Is a Major Determinant of Mitotic Cell Fate
- (2015) Caroline Topham et al. CANCER CELL
- Acute and sub-chronic toxicity studies of honokiol microemulsion
- (2015) Qianqian Zhang et al. REGULATORY TOXICOLOGY AND PHARMACOLOGY
- MYC is a critical target of FBXW7
- (2015) Mai Sato et al. Oncotarget
- Honokiol Suppresses Renal Cancer Cells’ Metastasis via Dual-Blocking Epithelial-Mesenchymal Transition and Cancer Stem Cell Properties through Modulating miR-141/ZEB2 Signaling
- (2014) Weidong Li et al. MOLECULES AND CELLS
- The Ubiquitin Ligase FBXW7 Modulates Leukemia-Initiating Cell Activity by Regulating MYC Stability
- (2013) Bryan King et al. CELL
- Gliomagenesis Arising from Pten- and Ink4a/Arf-Deficient Neural Progenitor Cells Is Mediated by the p53-Fbxw7/Cdc4 Pathway, Which Controls c-Myc
- (2012) H. S. Kim et al. CANCER RESEARCH
- Role of the ubiquitin ligase Fbw7 in cancer progression
- (2011) Yabin Cheng et al. CANCER AND METASTASIS REVIEWS
- The Fbw7 Tumor Suppressor Targets KLF5 for Ubiquitin-Mediated Degradation and Suppresses Breast Cell Proliferation
- (2010) Dong Zhao et al. CANCER RESEARCH
- miRNAs in human cancer
- (2010) Thalia A Farazi et al. JOURNAL OF PATHOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now